reSET® 1.4
reSET 1.4, a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Cognitive Behavioral Therapy Device For Psychiatric Disorders) made by Pear Therapeutics, Inc., was granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID on 12 Jul 2018 (UDI-DI 10851580008040); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026.
Active
De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10851580008040 | Date12 Jul 2018 | StatusListed |
| United States | FDA De NovoDENG | NumberDEN160018 | Date14 Sep 2017 | StatusActive |
Official records
- AccessGUDID record 10851580008040
- FDA De Novo database DEN160018
From the FDA record
- Device description
- reSET Web Dashboard is available using an internet browser. reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: · increase abstinence from a patient’s substances of abuse during treatment, and · increase retention in the outpatient treatment program.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA De Novo DEN160018 decided 14 Sep 2017 Active
- FDA GUDID UDI-DI 10851580008040 listed 12 Jul 2018 Listed
Timeline
- Granted FDA De Novo DEN160018
- Listed FDA GUDID 10851580008040
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- Trade name
- reSET®
- Generic name
- Mental health/function therapeutic software, screen-viewed
- Model / reference
- 1.4
- Primary DI / UDI-DI
- 10851580008040
- De Novo Number
- FDA product code
- PWE
- GMDN term
- Mental health/function therapeutic software, screen-viewed
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- Not in Commercial Distribution